Born: 1973
Re-elected in 2021. Elective in 2024
Competencies and special tasks on the Board
Education
- Cand. merc. International Marketing & Management, Copenhagen Business School (2000)
- MBA, Economics, Solvay Business School i Bruxelles (1998)
Professional experience
- CEO, Ambu (2022-)
- CEO, Atos Medical (2019-2022)
- CEO, Zealand Pharma (2015-2019)
- CEO, Dako (2013-2014)
- Novo Nordisk, ending as Corporate VP, Global Marketing (2002-2013)
- Management Consultant, McKinsey & Company (2000-2002)
- Marketing Associate, PPU Maconomy (1998-2000)
Positions within the Hempel Group
- Member of the Board of Trustees of the Hempel Foundation (2018-)
- Member of the Board of Directors of Hempel Invest A/S (2018-)
Independence
- The member is considered independent: Yes